Hot Stocks
| ShowHide Related Items >><< - 01/24/23
- Velodyne Lidar has not yet reached stockholder votes required for Ouster merger
- 01/12/23
- Velodyne announces Glass, Lewis, & Co recommends stockholders vote 'FOR' merger
- 01/03/23
- Ouster to supply digital lidar sensors to Cyngn autonomous driving platform
- 11/07/22
- Ouster, Velodyne Lidar announce proposed merger of equals
- 01/24/23
- Velodyne Lidar has not yet reached stockholder votes required for Ouster merger
- 01/12/23
- Velodyne announces Glass, Lewis, & Co recommends stockholders vote 'FOR' merger
- 11/17/22
- Velodyne Lidar signs multi-year agreement with GreenValley International
- 11/07/22
- Ouster, Velodyne Lidar announce proposed merger of equals
- 12/07/22 Citi
- Ouster downgraded to Neutral from Buy at Citi
- 11/09/22 Oppenheimer
- Velodyne Lidar downgraded to Perform from Outperform at Oppenheimer
- 11/09/22 Craig-Hallum
- Velodyne Lidar upgraded to Hold from Sell at Craig-Hallum
- 11/08/22 Baird
- Ouster downgraded to Neutral from Outperform at Baird
- 12/07/22 Citi
- Velodyne Lidar price target lowered to $1.30 from $1.70 at Citi
- 11/09/22 Oppenheimer
- Velodyne Lidar downgraded to Perform from Outperform at Oppenheimer
- 11/09/22 Craig-Hallum
- Velodyne Lidar upgraded to Hold from Sell at Craig-Hallum
- 11/01/22 WestPark Capital
- Velodyne Lidar initiated with an Underperform at WestPark Capital
- 11/07/22
- Ouster backs FY22 revenue view $40M-$55M, consensus $46.14M
- 11/07/22
- Ouster reports Q3 EPS (20c), consensus (17c)
- 11/08/22
- Velodyne Lidar sees Q4 revenue $12M-$14M, consensus $11.77M
- 11/08/22
- Velodyne Lidar reports Q3 adjusted EPS (13c), consensus (20c)
- 11/14/22
- What You Missed This Week in EVs and Clean Energy
- 11/07/22
- What You Missed On Wall Street On Monday
- 11/07/22
- What You Missed On Wall Street This Morning
- 11/07/22
- What You Missed This Week in EVs and Clean Energy
- 11/14/22
- What You Missed This Week in EVs and Clean Energy
- 11/07/22
- What You Missed On Wall Street On Monday
- 11/07/22
- What You Missed On Wall Street This Morning
- 11/07/22
- What You Missed This Week in EVs and Clean Energy
|
Hot Stocks
| ShowHide Related Items >><< - 01/25/23
- LendingTree CEO buys $2.08M in common stock
- 11/08/22 Oppenheimer
- LendingTree price target lowered to $35 from $55 at Oppenheimer
- 07/29/22 Truist
- LendingTree price target lowered to $80 from $130 at Truist
- 07/29/22 Susquehanna
- LendingTree price target lowered to $59 from $160 at Susquehanna
- 07/29/22 Oppenheimer
- LendingTree price target lowered to $55 from $120 at Oppenheimer
- 11/03/22
- LendingTree narrows FY22 revenue view to $985M-$1B from 985M-$1.015B
- 11/03/22
- LendingTree sees Q4 revenue $202M-$217M, consensus $217.57M
- 11/03/22
- LendingTree reports Q3 adjusted EPS (36c), consensus ($1.00)
|
Earnings
|
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c. ShowHide Related Items >><< - 01/27/23
- Eli Lilly says FDA approves Jaypirca
- 01/24/23
- Eli Lilly trading resumes
- 01/24/23
- Eli Lilly trading halted, volatility trading pause
- 01/24/23
- Eli Lilly to invest $450M to expand manufacturing at Research Triangle Park
- 01/27/23
- Merck's Keytruda approved by FDA for non-small cell lung cancer treatment
- 01/26/23
- Merck Animal Health announces FDA approval for Bravecto Chews for Dogs
- 01/25/23
- Merck to stop Phase 3 KEYNOTE-991 trial
- 01/25/23
- Merck reports 'positive' results from Phase 3 KEYNOTE-966 trial
- 01/31/23
- Prothena reports 'positive' topline Phase 1 study results for PRX005
- 01/27/23
- Bristol-Myers announces CHMP opinion recommending approval for Reblozyl
- 01/27/23
- Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP
- 01/26/23
- iVexSol closes $23.8M Series A-3 financing
- 12/19/22
- Honeywell confirms resolutions with DOJ, SEC, Brazil for $203M
- 12/19/22
- Honeywell pays $160M to resolve bribery investigations in U.S., Brazil
- 12/19/22
- Honeywell pays $81M to settle SEC Foreign Corrupt Practices charges
- 12/16/22
- Verra Mobility names Jon Keyser as Chief Legal Officer
- 11/15/22
- Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder
- 11/15/22
- Estee Lauder to acquire TOM FORD brand
- 11/02/22
- Estee Lauder raises quarterly dividend 10% to 66c from 60c per share
- 11/01/22
- Mondelez announces three new members to senior management team
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 08/31/22
- Hershey names Marlene Creighton as Global Chief Sales Officer
- 11/01/22
- Sirius XM continues to expect positive 2022 self-pay net subscriber additions
- 11/01/22
- Sirius XM reports Q3 self-pay subscribers 32.3M
- 11/01/22
- Sirius XM raises quarterly cash dividend 10%
- 10/31/22
- Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 09/15/22
- PayrHealth announces collaboration with Cardinal Health
- $148.64 /
+0.035 (+0.02%) - 01/23/23
- Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test
- 12/08/22
- Quest Diagnostics partners with Northern Light Health in Maine
- 12/01/22
- Quest Diagnostics awarded group purchasing agreement by Premier
- 11/28/22
- Quest Diagnostics completes acquisition of LabCare
- 01/31/23
- Nevada reports December statewide gaming win up 14.3% to $1.31B
- 12/29/22
- Nevada reports November statewide gaming win down 7.62% to $1.22B
- 12/20/22
- New Jersey reports November gaming revenue up 0.3% to $441.1M
- 12/08/22
- Penn Entertainment announces $750M share buyback program
- 01/20/23 William Blair
- Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair
- 01/12/23 Guggenheim
- Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks
- 01/03/23 Barclays
- Eli Lilly price target raised to $400 from $395 at Barclays
- 12/23/22 Raymond James
- ProQR Therapeutics price target raised to $5 from $2 at Raymond James
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/04/23 BofA
- Merck upgraded to Buy at BofA on consistent revenue upside
- 01/04/23 BofA
- Merck upgraded to Buy from Neutral at BofA
- 01/03/23 Wells Fargo
- Merck price target raised to $125 from $110 at Wells Fargo
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/17/23 Cantor Fitzgerald
- Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
- 12/23/22 William Blair
- NccRCC 'material expansion opportunity' for Exelixis, says William Blair
- 11/17/22 Credit Suisse
- Bristol-Myers initiated with a Neutral at Credit Suisse
- 01/04/23 UBS
- Honeywell downgraded to Sell from Buy at UBS
- 12/09/22 Citi
- Honeywell price target raised to $248 from $213 at Citi
- 12/05/22 Deutsche Bank
- Honeywell price target raised to $242 from $227 at Deutsche Bank
- 12/01/22 Barclays
- Honeywell price target raised to $229 from $212 at Barclays
- 01/31/23 Jefferies
- Bath & Body Works price target raised to $52 from $45 at Jefferies
- 01/24/23 Stifel
- Estee Lauder price target raised to $295 from $255 at Stifel
- 01/23/23 Deutsche Bank
- Estee Lauder price target raised to $290 from $266 at Deutsche Bank
- 01/17/23 Oppenheimer
- Estee Lauder price target raised to $300 from $245 at Oppenheimer
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 01/03/23 Wells Fargo
- Hershey initiated with an Underweight at Wells Fargo
- 12/20/22 Morgan Stanley
- Hershey price target raised to $231 from $224 at Morgan Stanley
- 12/08/22 UBS
- Hershey upgraded to Buy from Neutral at UBS
- 01/03/23 JPMorgan
- Sirius estimates cut on 'challenged' advertising market at JPMorgan
- 12/01/22 Citi
- Sirius XM downgraded to Sell from Buy at Citi
- 11/02/22 Deutsche Bank
- Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank
- 11/02/22 Pivotal Research
- Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 11/22/22 Credit Suisse
- Cardinal Health price target raised to $79 from $64 at Credit Suisse
- 11/14/22 Mizuho
- Cardinal Health price target raised to $74 from $66 at Mizuho
- 11/07/22 Baird
- Cardinal Health price target raised to $82 from $74 at Baird
- $148.64 /
+0.035 (+0.02%) - 01/23/23 Evercore ISI
- Quest Diagnostics initiated with an In Line at Evercore ISI
- 01/12/23 Baird
- Quest Diagnostics price target raised to $154 from $143 at Baird
- 12/14/22 Mizuho
- Quest Diagnostics price target raised to $165 from $160 at Mizuho
- 11/17/22 Citi
- Quest Diagnostics downgraded to Sell from Neutral at Citi
- 01/20/23 JMP Securities
- Penn Entertainment price target lowered to $45 from $48 at JMP Securities
- 01/11/23 Truist
- Penn Entertainment price target lowered to $36 from $40 at Truist
- 01/09/23 Jefferies
- Penn Entertainment downgraded to Hold at Jefferies as focus narrows
- 01/09/23 Jefferies
- Penn Entertainment downgraded to Hold from Buy at Jefferies
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 12/13/22
- Eli Lilly sees FY23 EPS $8.10-$8.30, consensus $9.15
- 12/13/22
- Eli Lilly backs FY22 EPS view $7.70-$7.85, consensus $7.78
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 10/27/22
- Merck raises FY22 adjusted EPS view to $7.32-$7.37 from $7.25-$7.35
- 10/27/22
- Merck reports Q3 adjusted EPS $1.85, consensus $1.71
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 10/25/22
- Notable companies reporting before tomorrow's open
- 10/25/22
- Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/18/22
- Honeywell reaffirms Q4, 2022 guidance after asbestos settlement
- 10/27/22
- Honeywell sees Q4 adjusted EPS $2.46-$2.56, consensus $2.51
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/02/22
- Estee Lauder cuts FY23 adjusted EPS view to $5.25-$5.40. from $7.39-7.54
- 11/02/22
- Estee Lauder sees Q2 adjusted EPS $1.19-$1.29, consensus $2.81
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/04/22
- Hershey raises FY22 adjusted EPS view to $8.20-$8.27 from $8.05-$8.20
- 11/04/22
- Hershey reports Q3 adjusted EPS $2.17, consensus $2.10
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/01/22
- Sirius XM reports Q3 adjusted EPS 7c, consensus 8c
- 11/01/22
- Sirius XM sees FY22 revenue $9B, consensus $9.04B
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/04/22
- Cardinal Health backs FY23 EPS view $5.05-$5.40, consensus $5.24
- 11/04/22
- Cardinal Health reports Q1 EPS $1.20, consensus 94c
- $148.64 /
+0.035 (+0.02%) - 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 10/20/22
- Quest Diagnostics raises FY22 adjusted EPS view to $9.75-$9.95 from $9.55-$9.95
- 10/20/22
- Quest Diagnostics reports Q3 adjusted EPS $2.36, consensus $2.19
- 20:25 Today
- Notable companies reporting before tomorrow's open
- 13:50 Today
- Notable companies reporting before tomorrow's open
- 11/03/22
- Penn Entertainment reports Q3 EPS 72c, consensus 38c
- 11/02/22
- Notable companies reporting before tomorrow's open
- 12/19/22
- Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 10/11/22
- New quality issues found at Eli Lilly drug plant, Reuters reports
- 08/13/22
- Eli Lilly, Novo Nordisk weight-loss drugs could be blockbusters, Barron's says
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/11/23
- Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says
- 12/30/22
- Merck's Covid treatment gets conditional approval in China, Reuters reports
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 01/04/23
- Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says
- 10/20/22
- Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports
- 09/19/22
- Defense companies urged to limit use of Chinese supplies, WSJ reports
- 11/16/22
- Zegna to acquire rest of Tom Ford International, Bloomberg reports
- 11/15/22
- Estee Lauder to acquire Tom Ford in deal valued at $2.8B, WSJ reports
- 11/15/22
- Estee Lauder nearing deal to acquire Tom Ford for $2.8B, WSJ reports
- 11/11/22
- Estee Lauder near deal to acquire Tom Ford for $2.8B, FT reports
- 12/30/22
- Hershey sued over metals content in dark chocolate, Reuters says
- 12/19/22
- Hershey among brands called out by Consumer Reports for lead exposure
- 12/01/22
- Sirius XM to cut staff amid faltering sales growth, Bloomberg reports
- 12/01/22
- Sirius XM to reduce staff in coming weeks, Bloomberg reports
- 08/31/22
- James Van Der Beek sues SiriusXM over podcast deal, THR reports
- 09/22/22
- Activist Elliott would like to see Pinterest put up for sale, Barron's says
- 08/15/22
- Elliott has large stake in Cardinal Health, seeks board seats, WSJ says
- $148.64 /
+0.035 (+0.02%) - 12/19/22
- Doctors gain confidence in new Alzheimer's blood tests, Bloomberg reports
- 01/23/23
- Biotech Alert: Searches spiking for these stocks today
- 01/20/23
- What You Missed On Wall Street This Morning
- 01/20/23
- Fly Intel: Pre-market Movers
- 12/19/22
- What You Missed On Wall Street On Monday
- 01/12/23
- Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover
- 01/04/23
- What You Missed On Wall Street This Morning
- 01/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/15/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Biotech Alert: Searches spiking for these stocks today
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/10/22
- Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo
- 01/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/19/22
- What You Missed On Wall Street On Monday
- 11/18/22
- What You Missed On Wall Street On Friday
- 10/27/22
- What You Missed On Wall Street On Thursday
- 12/17/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/10/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/07/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/08/22
- What You Missed On Wall Street On Thursday
- 12/08/22
- What You Missed On Wall Street This Morning
- 12/01/22
- What You Missed On Wall Street On Thursday
- 12/01/22
- What You Missed On Wall Street This Morning
- 11/28/22
- Fly Insider: Autoscope, Archer Aviation among week's notable insider trades
- 11/01/22
- Fly Intel: Pre-market Movers
- 11/04/22
- Fly Intel: Pre-market Movers
- 09/28/22
- #SocialStocks: Details of Musk's deposition by Twitter still being hammered out
- 08/15/22
- What You Missed On Wall Street On Monday
- 08/11/22
- Fly Intel: Pre-market Movers
- $148.64 /
+0.035 (+0.02%) - 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/19/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/20/22
- Fly Intel: Pre-market Movers
- 01/20/23
- Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization
- 01/13/23
- Bet On It: PlayUp SPAC deal terminated
- 01/09/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/06/23
- Bet On It: Three downstate New York casino licenses now up for grabs
- 11/01/22
- Unusually active option classes on open November 1st
- 10/03/22
- Eli Lilly And Co put volume heavy and directionally bearish
- 09/28/22
- Early notable gainers among liquid option names on September 28th
- 09/28/22
- Unusually active option classes on open September 28th
- 01/10/23
- Largest borrow rate increases among liquid names
- 12/07/22
- Largest borrow rate increases among liquid names
- 11/14/22
- Early notable gainers among liquid option names on November 14th
- 10/10/22
- Early notable gainers among liquid option names on October 10th
- 09/29/22
- Early notable gainers among liquid option names on September 29th
- 09/12/22
- Early notable gainers among liquid option names on September 12th
- 09/12/22
- Unusually active option classes on open September 12th
- 09/08/22
- Notable open interest changes for September 8th
- 01/18/23
- Honeywell put volume heavy and directionally bearish
- 12/21/22
- Early notable gainers among liquid option names on December 21st
- 11/04/22
- Early notable gainers among liquid option names on November 4th
- 11/16/22
- Early notable gainers among liquid option names on November 16th
- 14:15 Today
- Sirius XM put volume heavy and directionally bearish
- 01/05/23
- Largest borrow rate increases among liquid names
- 12/30/22
- Sirius XM call volume above normal and directionally bullish
- 12/22/22
- Sirius XM put volume heavy and directionally bearish
- 12/02/22
- Early notable gainers among liquid option names on December 2nd
- 11/11/22
- Cardinal Health put volume heavy and directionally bearish
- 10/10/22
- Cardinal Health call volume above normal and directionally bullish
- 08/12/22
- Early notable gainers among liquid option names on August 12th
- 12/14/22
- Penn National call volume above normal and directionally bullish
- 12/09/22
- Unusually active option classes on open December 9th
- 12/08/22
- Penn National put volume heavy and directionally bearish
- 11/14/22
- Penn National call volume above normal and directionally bullish
|
Hot Stocks
| ShowHide Related Items >><< - 10/05/22
- mdf Commerce sells InterTrade Systems to SPS Commerce for $48.5M
- 10/05/22
- SPS Commerce acquires InterTrade Systems for $49M in cash
- 12/14/22 Baird
- Baird staying selective in vertical software, makes four rating changes
- 12/14/22 Baird
- SPS Commerce downgraded to Neutral from Outperform at Baird
- 10/05/22 Stifel
- SPS Commerce price target raised to $150 from $140 at Stifel
- 07/28/22 Craig-Hallum
- SPS Commerce price target lowered to $160 from $210 at Craig-Hallum
- 10/27/22
- SPS Commerce raises FY22 EPS view to $2.23-$2.24 from $2.13-$2.15
- 10/27/22
- SPS Commerce sees Q4 EPS 52c-53c, consensus 54c
- 10/27/22
- SPS Commerce reports Q3 EPS 63c, consensus 52c
- 10/27/22
- Fly Intel: After-Hours Movers
|
Recommendations
| ShowHide Related Items >><< - 16:19 Today
- Costco reports January sales up 6.9% to $16.84B
- 01/19/23
- Costco announces reauthorization of stock repurchase program of up to $4B
- 01/10/23
- Evofem: Phexxi added to Costco Member Prescription Program
- 01/05/23
- Costco reports December sales of $23.8B, up 7%
- 01/23/23 Cowen
- Costco price target lowered to $600 from $650 at Cowen
- 01/06/23 DA Davidson
- Costco price target raised to $478 from $470 at DA Davidson
- 12/21/22 Tigress Financial
- Costco price target lowered to $635 from $678 at Tigress Financial
- 12/19/22 Credit Suisse
- Costco assumed with a Neutral at Credit Suisse
- 12/08/22
- Costco reports Q1 EPS $3.07, consensus $3.11
- 12/08/22
- Notable companies reporting after market close
- 11/30/22
- Costco Reports Q1 revenue $53.44B, consensus $54.9B
- 09/22/22
- Costco reports Q4 total revenue $72.1M, consensus $72.04B.
- 12/24/22
- Great time to buy Costco stock, Barron's says
- 01/19/23
- Fly Intel: After-Hours Movers
- 01/05/23
- Fly Intel: After-Hours Movers
- 12/09/22
- What You Missed On Wall Street On Friday
- 12/09/22
- What You Missed On Wall Street This Morning
- 01/06/23
- Early notable gainers among liquid option names on January 6th
- 01/06/23
- Unusually active option classes on open January 6th
- 12/08/22
- Costco options imply 3.7% move in share price post-earnings
- 12/01/22
- Unusually active option classes on open December 1st
|
Hot Stocks
| ShowHide Related Items >><< - 01/31/23
- Cathie Wood's ARK Investment bought 1.1M shares of Invitae today
- 01/19/23
- Cathie Wood's ARK Investment bought 724.8K shares of Invitae today
- 01/18/23
- Cathie Wood's ARK Investment bought 392.6K shares of Invitae today
- 01/17/23
- Cathie Wood's ARK Investment bought 250K shares of Invitae today
- 01/31/23 Goldman Sachs
- Invitae downgraded to Sell from Neutral at Goldman Sachs
- 08/24/22 Credit Suisse
- Invitae initiated with an Underperform at Credit Suisse
- 08/17/22 Piper Sandler
- Invitae price target lowered to $2.25 from $2.50 at Piper Sandler
- 08/10/22 JPMorgan
- Invitae cut to Underweight at JPMorgan with future growth yet to be proven
- 01/09/23
- Invitae reports preliminary FY22 metrics
- 11/08/22
- Invitae backs FY22 revenue growth of low double digits, consensus $517.43M
- 11/08/22
- Invitae reports Q3 adjusted EPS (42c), consensus (63c)
- 11/08/22
- Notable companies reporting after market close
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 11/09/22
- What You Missed On Wall Street This Morning
- 11/08/22
- Fly Intel: After-Hours Movers
- 11/08/22
- Invitae options imply 17.7% move in share price post-earnings
- 08/12/22
- Unusually active option classes on open August 12th
- 08/11/22
- Invitae call buyer realizes 3500% same-day gains
|
Hot Stocks
| ShowHide Related Items >><< - 01/31/23
- Cathie Wood's ARK Investment bought 20.7K shares of Velo3D today
- 01/30/23
- Cathie Wood's ARK Investment bought 127.7K shares of Velo3D today
- 01/12/23
- Velo3D appoints Stamp as Director of Solutions Engineering
- 11/15/22
- Velo3D announces order from Vertex Manufacturing for new Sapphire XC printers
- 08/16/22 Credit Suisse
- Velo3D initiated with a Neutral at Credit Suisse
- 05/11/22 Needham
- Velo3D price target lowered to $6 from $15 at Needham
- 03/04/22 BofA
- Velo3D downgraded to Underperform from Neutral at BofA
- 03/04/22 BofA
- Velo3D downgraded to Underperform from Neutral at BofA
- 11/08/22
- Velo3D cuts FY22 revenue view to $75M-$80M from $89M
- 11/08/22
- Velo3D sees Q4 revenue $24M-$29M, consensus $31.6M
- 11/08/22
- Velo3D reports Q3 EPS (12c), consensus (11c)
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- 09/14/22
- Fly Intel: After-Hours Movers
|
Hot Stocks
| |
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 01/30/23
- Vera Therapeutics reports Phase 2 results of atacicept in IgA nephropathy
- 01/25/23
- Vera Therapeutics to host KOL webinar on atacicept
- 01/03/23
- Vera Therapeutics shares fall 67% despite ORIGIN trial meeting primary endpoint
- 01/03/23
- Vera Therapeutics announces ORIGIN clinical trial met primary endpoint
- 16:36 Today
- Tenax receives NOA from USPTO for patent for levosimendan in PH-HFpEF
- 01/04/23
- Tenax Therapeutics announces 1-for-20 reverse stock split
- 10/10/22
- Tenax Therapeutics announces presentation of data from study of levosimendan
- 09/15/22
- Tenax Therapeutics trading resumes
- 01/04/23
- Roivant Sciences up 9% in pre-market at $7.78 after RVT-3101 phase 2b study data
- 01/04/23
- Roivant Sciences announces 'positive' results from Phase 2b study of RVT-3101
- 12/01/22
- Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101
- 11/10/22
- Roivant's Affivant to present data on AFVT-2101 at SITC
- 11/28/22
- Qorvo partners with MediaTek to secure design wins
- 11/02/22
- Qorvo, SK Siltron CSS enter SiC supply agreement
- 11/02/22
- Qorvo announces $2B share repurchase program
- 08/30/22
- Qorvo appoints Grant Brown as CFO
- 11/17/22
- PTC to acquire ServiceMax for $1.46B in cash
- 11/14/22
- Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes
- 10/19/22
- MaxLinear, SoftAtHome team on prpl LCM solution for home gateways
- 09/01/22
- Digi International selects MaxLinear PCIe bridges, serial transceivers
- 08/31/22
- Silicon Motion shareholders approve acquisition by MaxLinear
- $153.10 /
+4.135 (+2.78%) - 17:25 Today
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 17:18 Today
- Meta says 2023 will be 'a year of efficiency'
- 16:14 Today
- Meta Platforms announces $40B increase in share repurchase authorization
- 16:10 Today
- Meta Platforms reports FoA and RL segment restructuring charges
- 09/29/22
- McKesson extends pharmaceutical distribution agreement with CVS Health
- 09/19/22
- McKesson signs agreement to acquire Rx Savings Solutions
- 09/19/22
- McKesson to acquire Rx Savings Solutions for $600M upfront
- 09/13/22
- McKesson names LeAnn Smith chief human resources officer
- 12/30/22
- Intevac signs joint development agreement with glass, glass ceramic provider
- 10/26/22
- Intevac gets $12M order for hard disk drive technology upgrades
- 12/06/22
- Hologic's new data identifies patients benefiting from endocrine therapy
- 11/25/22
- Hologic to showcase portfolio of breast, skeletal health solutions at RSNA 2022
- 11/02/22
- Hologic awarded $19M BARDA contract
- 10/23/22
- Fly Intel: Top five weekend stock stories
- 12/05/22
- Ezcorp increases investment in Florida and Caribbean
- 11/17/22
- EZCORP trading resumes
- 11/17/22
- EZCORP trading halted, volatility trading pause
- 08/22/22
- Ezcorp launches Buy More, Earn More promotion
- 11/03/22
- e.l.f. Beauty rises 10.2%
- 01/18/23
- 8x8 announces approximately 7% reduction in workforce
- 12/13/22
- Matterport appoints Matthew Zinn as chief legal officer
- 12/08/22
- Spearline acquires Callstats from 8x8, terms not disclosed
- 11/30/22
- 8x8 terminates CEO Dave Sipes, Samuel Wilson named interim CEO
- 12/20/22
- Corteva Agriscience, Nevonex announce collaboration agreement
- 11/30/22
- Corteva to acquire Stoller Group for $1.2B
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 10/03/22
- Syngenta, Corteva sued by FTC for pay-to-black scheme
- 01/17/23
- Core Laboratories proposes redomestication of parent company to U.S.
- 10/26/22
- Core Laboratories CEO sees progress in onshore and offshore client activity
- 10/05/22
- ChampionX's US Synthetic weighs challenge to patent ruling
- 09/29/22
- ChampionX publishes first sustainability report
- $101.99 /
+1.755 (+1.75%) - 16:11 Today
- C.H. Robinson sees 2023 capital expenditures $90M-$100M
- 01/03/23
- C.H. Robinson CEO Bob Biesterfeld steps down, Scott Anderson named interim CEO
- 11/17/22
- C.H. Robinson raises quarterly dividend to 61c per share from 55c
- 11/02/22
- C.H. Robinson sees $175M of gross cost savings in Q4
- 10/27/22
- Century Communities falls -12.0%
- 10/26/22
- Century Communities CFO provides FY22 outlook
- $282.22 /
+12.72 (+4.72%) - 16:06 Today
- Align Technology board authorizes $1B buyback to succeed current program
- 10/31/22
- Align Technology CEO Joe Hogan to purchase additional $2M of common stock
- 10/31/22
- Align Technology announces $200M accelerated share repurchase agreement
- 10/26/22
- Align Technology falls 20% to $177.50 after Q3 results misses estimates
- $153.10 /
+4.135 (+2.78%) - 01/31/23 LightShed Partners
- Meta Platforms initiated with a Buy at LightShed Partners
- 01/30/23 DA Davidson
- DA Davidson neutral on Pinterest ahead of earnings
- 01/27/23 BofA
- BuzzFeed still a 'show me story,' Meta deal not new, says BofA
- 01/26/23 Piper Sandler
- Meta Platforms price target raised to $136 from $116 at Piper Sandler
- $282.22 /
+12.72 (+4.72%) - 01/11/23 Piper Sandler
- Align Technology price target raised to $255 from $230 at Piper Sandler
- 10/27/22 Stifel
- Align Technology price target lowered to $265 from $325 at Stifel
- 10/27/22 Baird
- Align Technology price target lowered to $260 from $310 at Baird
- 10/27/22 Piper Sandler
- Align Technology price target lowered to $230 from $300 at Piper Sandler
- 01/24/23 Stifel
- e.l.f. Beauty price target raised to $50 from $43 at Stifel
- 01/13/23 JPMorgan
- e.l.f. Beauty price target raised to $65 from $62 at JPMorgan
- 01/09/23 Jefferies
- e.l.f. Beauty downgraded to Hold from Buy at Jefferies
- 01/03/23 Piper Sandler
- e.l.f. Beauty price target raised to $64 from $55 at Piper Sandler
- 01/04/23 Canaccord
- Canaccord starts Ezcorp with a Buy, says discount 'undeserved'
- 01/04/23 Canaccord
- Ezcorp initiated with a Buy at Canaccord
- 04/05/22 Jefferies
- Ezcorp upgraded to Buy from Hold at Jefferies
- 12/15/22 Wedbush
- Wedbush starts 8x8 with a Neutral as momentum slows
- 12/14/22 Wedbush
- 8x8 initiated with a Neutral at Wedbush
- 12/02/22 Craig-Hallum
- Craig-Hallum sees 'tremendous logic' in RingCentral, 8x8 combination
- 10/28/22 Barclays
- 8x8 price target lowered to $4 from $5 at Barclays
- 01/03/23 Benchmark
- Intevac upgraded to Buy at Benchmark following TRIO agreement
- 01/03/23 Benchmark
- Intevac upgraded to Buy from Hold at Benchmark
- 02/10/22 Benchmark
- Intevac downgraded to Hold from Buy at Benchmark
- 01/24/23 Mizuho
- Hologic price target raised to $90 from $77 at Mizuho
- 01/10/23 Wells Fargo
- Hologic price target raised to $80 from $75 at Wells Fargo
- 12/06/22 RBC Capital
- Hologic initiated with a Sector Perform at RBC Capital
- 11/16/22 Evercore ISI
- Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list
- 01/09/23 BofA
- Core Laboratories upgraded to Neutral from Underperform at BofA
- 10/07/22 Piper Sandler
- Core Laboratories assumed with a Neutral at Piper Sandler
- 10/06/22 Citi
- Citi upgrades Core Laboratories to Neutral following pullback
- 10/06/22 Citi
- Core Laboratories upgraded to Neutral from Sell at Citi
- 01/31/23 UBS
- McKesson price target lowered to $440 from $450 at UBS
- 01/11/23 Baird
- McKesson price target raised to $445 from $440 at Baird
- 11/14/22 Mizuho
- McKesson price target raised to $376 from $345 at Mizuho
- 11/02/22 Cowen
- McKesson price target raised to $416 from $384 at Cowen
- 11/01/22 Citi
- ChampionX price target raised to $34 from $30 at Citi
- 10/07/22 Piper Sandler
- ChampionX assumed with an Overweight at Piper Sandler
- 10/06/22 Barclays
- ChampionX downgraded on less potential upside potential at Barclays
- 10/06/22 Barclays
- ChampionX downgraded to Equal Weight from Overweight at Barclays
- 11/02/22 Needham
- Silicon Motion upgraded to Buy at Needham after 'better than feared' report
- 10/26/22 Northland
- MaxLinear price target lowered to $35 from $45 at Northland
- 10/26/22 Craig-Hallum
- MaxLinear price target lowered to $55 from $65 at Craig-Hallum
- 10/26/22 Susquehanna
- MaxLinear price target lowered to $42 from $45 at Susquehanna
- 01/30/23 RBC Capital
- PTC price target raised to $155 from $140 at RBC Capital
- 01/26/23 Baird
- PTC price target raised to $165 from $150 at Baird
- 01/23/23 KeyBanc
- PTC upgraded to Overweight from Sector Weight at KeyBanc
- 01/11/23 Barclays
- PTC price target lowered to $144 from $148 at Barclays
- $101.99 /
+1.755 (+1.75%) - 01/17/23 BofA
- Schneider, Werner upgraded to Buy, XPO Logistics downgraded at BofA
- 01/17/23 BofA
- C.H. Robinson downgraded to Underperform from Neutral at BofA
- 01/11/23 JPMorgan
- C.H. Robinson downgraded to Neutral from Overweight at JPMorgan
- 01/11/23 KeyBanc
- C.H. Robinson price target lowered to $110 from $120 at KeyBanc
- 01/20/23 Citi
- Corteva price target lowered to $72 from $75 at Citi
- 01/18/23 Wells Fargo
- Corteva initiated with an Overweight at Wells Fargo
- 01/18/23 Wells Fargo
- Corteva initiated with an Overweight at Wells Fargo
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/23/23 Barclays
- Qorvo price target raised to $110 from $85 at Barclays
- 01/17/23 Citi
- Citi opens 'positive catalyst watch' on Qorvo
- 01/11/23 KeyBanc
- KeyBanc says iPhone survey shows supply partial recovery, some shortages remain
- 01/09/23 Wells Fargo
- Qorvo price target raised to $90 from $80 at Wells Fargo
- 01/20/23 B. Riley
- Century Communities price target raised to $49 from $44 at B. Riley
- 12/30/22 Wedbush
- Wedbush favors four homebuilding stocks heading into 2023
- 11/29/22 BTIG
- Century Communities initiated with a Neutral at BTIG
- 11/22/22 JPMorgan
- Century Communities downgraded to Underweight from Overweight at JPMorgan
- 01/04/23 Jefferies
- Vera Therapeutics downgraded to Hold from Buy at Jefferies
- 01/04/23 Wedbush
- Wedbush downgrades Vera Therapeutics to Neutral, lowers price target to $8
- 01/04/23 Wedbush
- Vera Therapeutics downgraded to Neutral from Outperform at Wedbush
- 01/04/23 H.C. Wainwright
- Vera Therapeutics price target lowered to $15 from $36 at H.C. Wainwright
- 01/05/23 Citi
- Roivant Sciences price target raised to $14 from $11 at Citi
- 01/04/23 Piper Sandler
- Prometheus, Roivant TL1A data look 'highly competitive,' says Piper
- 12/28/22 Cantor Fitzgerald
- Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
- 12/27/22 Cantor Fitzgerald
- Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald
- 11/09/22
- Vera Therapeutics reports Q3 EPS (91c), consensus (72c)
- 08/10/22
- Vera Therapeutics reports Q2 EPS (55c) vs (33c) last year
- 11/14/22
- Roivant Sciences reports Q2 EPS (42c), consensus (41c)
- 08/15/22
- Roivant Sciences reports Q1 EPS (48c) vs (13c) last year
- 16:04 Today
- Qorvo sees Q4 EPS 10c-15c, consensus 64c
- 16:02 Today
- Qorvo reports Q3 EPS 75c, consensus 63c
- 11/02/22
- Qorvo sees Q3 EPS 50c-75c, consensus $1.69
- 16:03 Today
- PTC raises FY23 revenue view to $2.070B-$2.150B from $2.050B-$2.130B
- 16:02 Today
- PTC reports Q1 adjusted EPS 99c, consensus $1.03
- 11/02/22
- PTC sees FY23 revenue $1.91B-$1.99B, consensus $1.92B
- 11/02/22
- PTC reports Q4 adjusted EPS $1.27, consensus $1.15
- 16:07 Today
- MaxLinear sees Q1 revenue $240M-$260M, consesus $279.7M
- 16:06 Today
- MaxLinear reports Q4 adjusted EPS $1.07, consensus $1.06
- 10/25/22
- MaxLinear sees Q4 revenue $285M-$295M, consensus $285.36M
- 10/25/22
- MaxLinear reports Q3 EPS $1.05, consensus $1.04
- $153.10 /
+4.135 (+2.78%) - 16:06 Today
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 16:06 Today
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 13:48 Today
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 16:14 Today
- McKesson raises FY23 EPS view to $25.75-$26.15 from $24.45-$24.95
- 16:13 Today
- McKesson reports Q3 adjusted EPS $6.90, consensus $6.35
- 11/01/22
- McKesson boosts FY23 adjusted EPS view to $24.45-$24.95 from $23.95-$24.65
- 17:07 Today
- Intevac sees Q1 EPS (20c)-(16c), consensus (21c)
- 16:13 Today
- Intevac reports Q4 EPS (13c) vs. (25c) y/y
- 11/02/22
- Intevac sees Q4 EPS (21c)-(17c), consensus (12c)
- 08/03/22
- Intevac sees Q3 EPS (17c) to (15c), one estimate (13c)
- 16:03 Today
- Hologic raises FY23 EPS view to $3.55-$3.85 from $3.30-$3.60
- 16:02 Today
- Hologic sees Q2 adjusted EPS 80c-90c, consensus 82c
- 16:02 Today
- Hologic reports Q1 adjusted EPS $1.07, consensus 91c
- 01/08/23
- Hologic reports preliminary Q1 revenue $1.074B, consensus $966.37M
- 16:21 Today
- Ezcorp reports Q1 adjusted EPS 28c, consensus 22c
- 11/16/22
- Ezcorp reports Q4 adjusted EPS 15c, one estimate 12c
- 08/03/22
- Ezcorp reports Q3 adjusted EPS 16c, consensus 5c
- 16:10 Today
- e.l.f. Beauty raises FY23 adjusted EPS view to $1.37-$1.40 from $1.07-$1.10
- 16:09 Today
- e.l.f. Beauty reports Q3 adjusted EPS 48c, consensus 23c
- 11/02/22
- e.l.f. Beauty raises FY23 EPS view to $1.07-$1.10 from 84c-87c
- 11/02/22
- e.l.f. Beauty reports Q2 EPS 36c, consensus 16c
- 16:07 Today
- 8x8 raises FY23 revenue view to $743.4M-$746.4M from $720M-$730M
- 16:07 Today
- 8x8 sees Q4 revenue $184M-$187M, consensus $187.67M
- 16:06 Today
- 8x8 reports Q3 adjusted EPS 7c, consensus 3c
- 17:02 Today
- Corteva sees FY23 operating EPS $2.70-$2.90, consensus $3.13
- 17:01 Today
- Corteva reports Q4 adjusted EPS 16c, consensus 5c
- 11/03/22
- Corteva backs FY22 adjusted EPS view $2.45-$2.60, consensus $2.57
- 11/03/22
- Corteva reports Q3 adjusted EPS (12c), consensus (23c)
- 17:16 Today
- Core Laboratories reports Q4 EPS 20c, consensus 20c
- 10/26/22
- Core Laboratories reports Q3 EPS 18c, consensus 15c
- 16:36 Today
- ChampionX sees Q1 revenue $952M-$982M, consensus $994.58M
- 16:33 Today
- ChampionX reports Q4 EPS 33c, consensus 40c
- 10/25/22
- ChampionX sees Q4 revenue $985M-$1.015B, consensus $953.01M
- 10/25/22
- ChampionX reports Q3 adjusted EPS 33c, consensus 32c
- $101.99 /
+1.755 (+1.75%) - 16:09 Today
- C.H. Robinson reports Q4 adjusted EPS $1.03, consensus $1.38
- 11/02/22
- C.H. Robinson reports Q3 EPS $1.78, consensus $2.17
- 16:07 Today
- Century Communities reports Q4 adjusted EPS $2.71, consensus $2.43
- 10/26/22
- Century Communities reports Q3 EPS $4.44, consensus $4.20
- $282.22 /
+12.72 (+4.72%) - 16:05 Today
- Align Technology reports Q4 EPS $1.73, consensus $1.56
- 10/26/22
- Align Technology reports Q3 adjusted EPS $1.36, consensus $2.18
|
Hot Stocks
| ShowHide Related Items >><< - 01/25/23
- HSBC Bank Canada raises prime lending rate to 6.7% from 6.45%
- 01/03/23
- Kentucky lists BlackRock, Citi, JPMorgan as energy boycotters
- 12/14/22
- HSBC Bank USA raises prime lending rate to 7.5% from 7%
- 12/14/22
- HSBC updates climate policy to stop funding new oil, gas
- 01/30/23 Barclays
- Barclays upgrades European banks view to Positive from Neutral
- 01/16/23 Deutsche Bank
- Standard Chartered downgraded to Hold from Buy at Deutsche Bank
- 01/16/23 Deutsche Bank
- HSBC upgraded to Buy from Hold at Deutsche Bank
- 01/05/23 Jefferies
- HSBC upgraded to Buy from Hold at Jefferies
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- 12/21/22
- HSBC beats $141M lawsuit in U.K. over Allen Stanford, Reuters says
- 11/30/22
- HSBC to close 114 branches in the U.K. starting in April, Press Association says
- 11/04/22
- Ping An calls on HSBC to spin off Asian business, cut jobs, FT reports
- 10/04/22
- HSBC weighs sale of Canadian business, Reuters reports
- 11/29/22
- What You Missed On Wall Street On Tuesday
- 11/29/22
- What You Missed On Wall Street This Morning
- 11/04/22
- What You Missed On Wall Street On Friday
- 11/04/22
- What You Missed On Wall Street This Morning
- 01/10/23
- HSBC put volume heavy and directionally bearish
- 11/02/22
- HSBC put volume heavy and directionally bearish
- 10/31/22
- HSBC put volume heavy and directionally bearish
- 10/26/22
- HSBC put volume heavy and directionally bearish
|